N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failure

Yi Lu, Junzhe Chen, Licong Su, Andrew Fanuel Lukwaro, Shiyu Zhou, Shaoxin Zheng, Yuxin Luo, Sha Fu, Sheng Nie, Ying TangClinical 2024 · DOI

Abstract

Despite its strong inverse association with eGFR, NT-proBNP was positively associated with the risk of progression of kidney disease in CKD patients with stages 1-3 without HF. Future studies should investigate the effectiveness of NT-proBNP as a predictive biomarker for the progression of kidney disease across diverse racial groups and healthcare settings.
BibTeX
@inproceedings{lu2024n,
  author = {Yi Lu and Junzhe Chen and Licong Su and Andrew Fanuel Lukwaro and Shiyu Zhou and Shaoxin Zheng and Yuxin Luo and Sha Fu and Sheng Nie and Ying Tang},
  title = {{N-terminal pro-B-type natriuretic peptide, eGFR, and progression of kidney disease in chronic kidney disease patients without heart failure}},
  booktitle = {Clinical},
  year = {2024},
  doi = {10.1093/ckj/sfae298},
}

Loading related content...

Figure